Skip to content

Cigna CI Product — Revenue

Other product segments

Other external revenues
$159M-1.9%

Similar metrics at other companies

Quad Graphics logo
QUADProducts — Revenue
$456.2M-7.8%
AerSale Corporation logo
ASLEProduct — Revenue
$35.3M-4.9%
Syndax Pharmaceuticals logo
SNDXProduct — Revenue
$48.92M+144%
One Stop Systems, Inc. logo
OSSProduct — Revenue
$7.06M+47.3%
Kura Oncology logo
KURAProduct — Revenue
$5.77M
Innoviva, Inc. logo
INVAProduct — Revenue
$41.37M+36.6%

Other financials

Income statement

See full
Revenue$68.5B+4.6%
Gross profit$14.4B-15.8%
Operating income$2.4B+19.6%
Net income$1.7B+25.0%
EPS (diluted)$6.26+29.1%

Balance sheet

See full
Cash & equivalents$7.0B-15.5%
Total debt$111.0M+32.1%
Total equity$42.2B+4.9%
Total assets$153.27B+1.7%

Cash flow

See full
Operating cash flow$1.1B-41.1%

Valuation

See full
Market cap$74.56B-11.2%
P/E12×-4.9×
P/S0.3×-0.1×

Profitability

See full
Gross margin20.6%-5.2pp
Operating margin3.4%-0.1pp
Net margin2.2%+0.3pp
FCF margin5.5%

Returns & leverage

See full
Return on equity15%+2.8pp
Debt / equity0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Cigna in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cigna’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cigna's product — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cigna's product — revenue?
Cigna (CI) reported product — revenue of $54.04B in Q1 2026.
How has Cigna's product — revenue changed year-over-year?
Cigna's product — revenue increased by 11.1% year-over-year, from $48.63B to $54.04B.
What is the long-term trend for Cigna's product — revenue?
Over 4 years (2021 to 2025), Cigna's product — revenue has grown at a 15.6% compound annual growth rate (CAGR), from $121.41B to $216.67B.
What does product — revenue mean?
This metric represents the total revenue recognized from the sale of specific products or services within a defined business segment, excluding intercompany eliminations. It captures the inflow of economic benefits arising from the delivery of pharmacy benefit management, specialty pharmacy, or health insurance services to external customers. This figure is a primary indicator of the segment's market demand and its contribution to the overall enterprise top-line performance.